市場調査レポート
商品コード
1497833
臨床検査サービス市場:専門分野、用途、エンドユーザー別-2024-2030年の世界予測Clinical Laboratory Services Market by Speciality (Clinical Chemistry Testing, Cytology Testing, Drugs of Abuse Testing), Application (Blood Transfusion Services, Clinical Trials Support, Disease Diagnosis), End-User - Global Forecast 2024-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
臨床検査サービス市場:専門分野、用途、エンドユーザー別-2024-2030年の世界予測 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
臨床検査サービス市場規模は、2023年に2,526億6,000万米ドルと推定され、2024年には2,648億4,000万米ドルに達し、CAGR 5.00%で2030年には3,557億2,000万米ドルに達すると予測されています。
臨床検査サービスは、個人の健康状態に関する重要な情報を得ることを目的として、専門の検査室で実施される包括的な検査や試験を指します。これらのサービスは、病気の診断、治療、モニタリング、予防ヘルスケア管理において極めて重要な役割を果たします。ヘルスケアプロバイダーが利用する臨床検査サービスには、血液、組織、その他の体液に関する様々な検査が含まれます。臨床検査サービスの普及により、疾病や感染症の有病率が上昇し、高齢者人口が増加しています。加えて、早期かつ正確な疾病診断に対する需要の高まりやヘルスケアインフラの整備も市場拡大に寄与しています。しかし、成長を阻害する要因としては、新サービスの導入を遅らせる厳しい規制の枠組みや、高度な診断の高コストなどが挙げられます。さらに、ラボにおけるデジタル病理学プラットフォームや自動化システムの導入が増加していることは、市場に大きな機会をもたらしています。
主な市場の統計 | |
---|---|
基準年[2023] | 2,526億6,000万米ドル |
予測年[2024] | 2,648億4,000万米ドル |
予測年 [2030] | 3,557億2,000万米ドル |
CAGR(%) | 5.00% |
地域別インサイト
アメリカ地域は臨床検査サービス市場の最前線に位置し、最先端技術の導入、強固な規制枠組み、多額のヘルスケア支出によって牽引されています。南北アメリカの消費者需要は個別化医療や精密医療に傾いており、検査施設は先進的なゲノム・分子診断技術の導入に影響を受けています。同地域における最近の技術革新は、診断における自動化と人工知能(AI)の応用に重点を置き、精度と納期を向上させています。欧州地域は、加盟国間でヘルスケア制度や規制が異なる多様な市場です。検査室基準の調和とデジタルカルテの導入に強い傾向があります。中東では、政府主導のヘルスケア改革とヘルスケアインフラへの投資により、臨床検査サービス市場が急成長しています。APAC地域の臨床検査サービスは、政府のヘルスケアインフラへの投資と中間層の増加により急速に拡大しています。感染症検査と慢性疾患管理に重点が置かれ、公衆衛生の優先順位と一致しています。
FPNVポジショニング・マトリックス
FPNVポジショニングマトリックスは、臨床検査サービス市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、臨床検査サービス市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査対象期間の累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と推奨
戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、臨床検査サービス市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
[195 Pages Report] The Clinical Laboratory Services Market size was estimated at USD 252.66 billion in 2023 and expected to reach USD 264.84 billion in 2024, at a CAGR 5.00% to reach USD 355.72 billion by 2030.
Clinical laboratory services refer to a comprehensive range of tests and examinations conducted in specialized laboratories with the purpose of obtaining crucial information about the health status of an individual. These services play a pivotal role in the diagnosis, treatment, and monitoring of diseases, & in preventive healthcare management. Clinical laboratory services utilized by healthcare providers encompass various tests on blood, tissue, and other bodily fluids. The rising prevalence of diseases and infections coupled with the surging elderly populace owing to the deployment of clinical laboratory services. Additionally, the increasing demand for early and accurate disease diagnosis and healthcare infrastructure improvements contribute to the market's expansion. However, factors hindering the growth include stringent regulatory frameworks that delay the introduction of new services and the high cost of advanced diagnostics. Furthermore, the increasing implementation of digital pathology platforms and automated systems in labs poses significant opportunities to the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 252.66 billion |
Estimated Year [2024] | USD 264.84 billion |
Forecast Year [2030] | USD 355.72 billion |
CAGR (%) | 5.00% |
Regional Insights
The American region stands at the forefront of the clinical laboratory services market, driven by cutting-edge technological adoption, a robust regulatory framework, and significant healthcare spending. Consumer demand in the Americas leans towards personalized and precision medicine, influencing laboratories to adopt advanced genomic and molecular diagnostic technologies. Recent innovations in the region focus on automation and artificial intelligence (AI) applications in diagnostics, enhancing accuracy and turnaround times. The European region presents a diverse market with varying healthcare systems and regulations across member states. There is a strong inclination towards harmonizing laboratory standards and adopting digital health records. The Middle East is witnessing rapid growth in the clinical laboratory services market, underscored by government-led healthcare reforms and investments in healthcare infrastructure. Clinical laboratory services in the APAC region are rapidly expanding, powered by government investments in healthcare infrastructure and a growing middle class. The focus is on infectious disease testing and chronic disease management, aligning with public health priorities.
Market Insights
The market dynamics represent an ever-changing landscape of the Clinical Laboratory Services Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Laboratory Services Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Laboratory Services Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Agilus Diagnostics Expands Service Reach with a New State-of-the-Art Laboratory in Bongaigaon, Assam
Agilus Diagnostics has inaugurated a cutting-edge laboratory in Bongaigaon, Assam, significantly enhancing the region's diagnostic capabilities. The laboratory is designed to process over 25,000 samples monthly across a spectrum of tests, from basic to specialized, and the facility underscores Agilus's commitment to encountering the growing demand for high-quality diagnostic services. [Published On: 2023-11-23]
Enhancing Regional Healthcare through Strategic Acquisition by Labcorp
Labcorp announced its acquisition of the outreach laboratory business and certain operational assets from Baystate Health, Inc., including several laboratory service centers across Massachusetts. This pivotal move is set to enhance the existing reference laboratory collaboration between the two entities, aiming to boost the efficiency of both routine and specialty lab testing significantly. [Published On: 2023-10-04]
Enhancing In-Home Healthcare Through Strategic Partnership between Getlabs and Nice Healthcare
Getlabs has forged a strategic partnership with Nice Healthcare, a provider of both in-home and virtual primary care services. This collaboration aims to significantly broaden the reach of comprehensive healthcare services directly to patients' homes, leveraging Getlabs' expertise in facilitating over 5,000 lab tests remotely, & Nice Healthcare's robust virtual and in-home primary care solutions. [Published On: 2023-05-02]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Laboratory Services Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Clinical Laboratory Services Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACM Medical Laboratory, Inc., Amedes Medical Services GmbH, Arup Laboratories Inc., Bioreference Health, LLC by OPKO Health, Inc., Cerba HealthCare S.A.S., Charles River Laboratories, Clinical Reference Laboratory, Inc., DaVita Inc. by United HealthCare Service LLC, Empire City Laboratories, Inc., Eurofins Scientific SE, Exact Sciences Corporation, Genova Diagnostics, Laboratory Corporation of America Holdings, LifeLabs Inc., Millennium Health, LLC, Myriad Genetics, Inc., NeoGenomics, Inc., Quest Diagnostics Incorporated, SGS SA, Siemens Healthineers AG, Sonic Healthcare Ltd., SYNLAB International GmbH, Thermo Fisher Scientific Inc., and Unilabs AB by A.P Moller Holding.
Market Segmentation & Coverage